OGN News and Press, Organon & Co. From 06/07/23

Agreement is part of a transformative model convening governments, global development banks and other multilateral agencies to use results-based financing to improve the lives of women Today, Organon (NYSE:OGN), a global healthcare company focused on women’s health, and CAF, ...

2023-06-07 07:00:00 ET Summary Markets overreacted to Norwich suing the FDA. Investors must consider recently reported weak Q1 results of Bausch Health. Reasons BHC stock is a buy from here. Last summer, Bausch Health ( BHC ) traded with wild 11% drops . Vola...

ORGANON CANADA TO SUPPORT LE CHAÎNON BY FUNDING THE INITIAL CONSTRUCTION PHASE OF ITS MEDICAL CLINIC Canada NewsWire The project aims to facilitate access for Le Chaînon residents to medical consultations KIRKLAND, QC , May 18, 2023 /CNW/ - As p...

2023-05-08 11:41:03 ET Summary The share price of Organon & Co. has taken a dramatic tumble after reporting quarters with sluggish revenue and earnings numbers. The dividend is holding at about a 5% yield and its safety seems of only slight concern because the company has stro...

2023-05-04 14:28:38 ET Summary Organon reported obviously disappointing results today - OGN stock plunged more than 10% in response. In this update, I share my view on Organon's quarterly results and point out possible warning signs and reasons for the sell-off. I give an upda...

2023-05-04 12:05:35 ET Organon ( NYSE: OGN ) stock fell ~10% on Thursday after Q1 results. Adjusted EPS fell -34.5% Y/Y to $1.08 and also missed analysts' estimates. Revenue declined -1.8% Y/Y to ~$1.54B, but came in line with expectations. Excluding the impact of f...

2023-05-04 11:04:08 ET Organon & Co. (OGN) Q1 2023 Earnings Conference Call May 04, 2023 08:30 A.M. ET Company Participants Jennifer Halchak - VP, IR Kevin Ali - CEO Matthew Walsh - CFO Conference Call Participants Unidentified Analyst - Evercore ...

2023-05-04 07:31:34 ET Organon press release ( NYSE: OGN ): Q1 Non-GAAP EPS of $1.08 misses by $0.08 . Revenue of $1.54B (-1.9% Y/Y) in-line. Full year 2023 financial guidance ranges affirmed For further details see: Organon Non-GAAP EPS of $1.08 misses b...

First quarter 2023 revenue of $1,538 million First quarter 2023 diluted earnings per share of $0.69 and non-GAAP Adjusted diluted earnings per share of $1.08 Both reported and non-GAAP Adjusted diluted earnings per share include a negative impact of $0.03 per share for acquired in-process...

2023-05-03 14:25:08 ET Organon ( NYSE: OGN ) is scheduled to announce Q1 earnings results on Thursday, May 4th, before market open. The consensus EPS estimate is $1.16 and the consensus revenue estimate is $1.54B. Over the last 1 year, OGN has beaten EPS estimates ...